Education
About Us
Working with TipRanks
Follow Us
Xtant Medical Holdings (XTNT)
:XTNT
Total Valuation
Xtant Medical Holdings has a market cap or net worth of $65.36M. The enterprise value is $120.19M.
Market Cap$65.36M
Enterprise Value$120.19M
Share Statistics
Xtant Medical Holdings has 139.07M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding139.07M
Owened by Insiders10.31%
Owened by Instutions66.61%
Financial Efficiency
Xtant Medical Holdings’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee$540,396.313
Profits Per Employee-$75,806.452
Employee Count217
Asset Turnover1.25
Inventory Turnover1.27
Valuation Ratios
The current PE Ratio of Xtant Medical Holdings is -3.60. Xtant Medical Holdings’s PEG ratio is <0.01.
PE Ratio-3.60
PS Ratio0.50
PB Ratio1.38
Price to Fair Value1.38
Price to FCF-3.70
Price to Operating Cash Flow-4.98
PEG Ratio<0.01
Income Statement
In the last 12 months, Xtant Medical Holdings had revenue of $117.27M and earned -$16.45M in profits. Earnings per share was -$0.10.
Revenue$117.27M
Gross Profit$68.22M
Operating Income-$12.07M
Pretax Income-$16.26M
Net Income-$16.45M
EBITDA-7.88M
Earnings Per Share (EPS)-0.10
Cash Flow
In the last 12 months, operating cash flow was -$11.90M and capital expenditures -$4.11M, giving a free cash flow of -$16.01M billion.
Operating Cash Flow-$11.90M
Free Cash Flow-$16.01M
Free Cash Flow per Share-$0.12
Dividends & Yields
Xtant Medical Holdings pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.24
52-Week Price Change-51.61%
50-Day Moving Average0.52
200-Day Moving Average0.56
Relative Strength Index (RSI)45.32
Average Volume (3m)99.78K
Important Dates
Xtant Medical Holdings upcoming earnings date is May 7, 2025, After Close.
Last Earnings DateMar 6, 2025
Next Earnings DateMay 7, 2025
Ex-Dividend Date―
Financial Position
Xtant Medical Holdings as a current ratio of 2.35, with Debt / Equity ratio of 0.30
Current Ratio2.35
Quick Ratio1.00
Debt to Market Cap0.22
Net Debt to EBITDA―
Interest Coverage Ratio-2.90
Taxes
In the past 12 months, Xtant Medical Holdings has paid $187.00K in taxes.
Income Tax$187.00K
Effective Tax Rate-1.15%
Enterprise Valuation
Xtant Medical Holdings EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Xtant Medical Holdings has $6.20M in cash and marketable securities with $35.14M in debt, giving a net cash position of $28.94M billion.
Cash & Marketable Securities$6.20M
Total Debt$35.14M
Net Cash$28.94M
Net Cash Per Share$0.21
Tangible Book Value Per Share$0.20
Margins
Gross margin is 58.17%, with operating margin of -10.30%, and net profit margin of -14.03%.
Gross Margin58.17%
Operating Margin-10.30%
Pretax Margin-13.87%
Net Profit Margin-14.03%
EBITDA Margin-10.30%
EBIT Margin-10.32%
Analyst Forecast
The average price target for Xtant Medical Holdings is $2.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$2.00
Price Target Upside344.44%
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast28.44%
EPS Growth Forecast-61600.00%